Related Experiment Video
Updated: Sep 4, 2025
12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.7K
Myocarditis Following COVID-19 Vaccination
Constantin A Marschner1, Kirsten E Shaw2, Felipe Sanchez Tijmes3
1Department of Medical Imaging, Toronto General Hospital, Peter Munk Cardiac Center, University Health Network (UHN), University of Toronto, 1 PMB-298, 585 University Avenue, Toronto, Ontario M5G 2N2, Canada; Department of Radiology, University Hospital, LMU Munich, Munich 81377, Germany.
Cardiology Clinics
|July 19, 2022
Summary
Myocarditis is a rare side effect of COVID-19 vaccines, mainly affecting young males. Most cases show mild cardiac imaging changes and improve quickly with treatment.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- Messenger RNA (mRNA) vaccines for COVID-19 are widely used.
- Myocarditis, inflammation of the heart muscle, is a known rare adverse event.
- This condition is most frequently observed in adolescent and young adult males post-vaccination.
Purpose of the Study:
- To review the existing literature on myocarditis following COVID-19 vaccination.
- To analyze incidence, risk factors, clinical presentation, and imaging findings.
- To explore potential pathophysiologic mechanisms and the need for long-term follow-up.
Main Methods:
- Systematic review of current scientific literature.
- Analysis of reported cases of myocarditis post-COVID-19 vaccination.
- Evaluation of clinical data, cardiac imaging, and treatment outcomes.
Main Results:
- Myocarditis post-COVID-19 vaccination is rare but established.
- Onset typically occurs within days of vaccination.
- Most patients exhibit mild cardiac imaging abnormalities and respond well to standard treatment.
Conclusions:
- Further long-term follow-up is necessary to assess persistent imaging abnormalities and adverse outcomes.
- Understanding the risks associated with subsequent vaccinations is crucial.
- Continued research into the pathophysiology and long-term effects of vaccine-associated myocarditis is warranted.
Related Concept Videos
01:14Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
01:27Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
01:21Myocarditis I: Introduction
25
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
01:22Myocarditis IV: Nursing Management
22
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
22
01:22Pericarditis I: Introduction
18
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
18
01:17Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26